XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Operating activities    
Net income $ 7,826 $ 3,348
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 2,154 1,952
Provision for loan and lease losses 9,507 11,635
Net amortization of investment securities discounts/premiums 748 223
Stock-based compensation expense 1,253 814
Mortgage loans originated for sale (233) (458)
Sale of mortgage loans originated for resale 237 462
Gain on sale of mortgage loans originated for resale (4) (4)
Deferred income tax benefit 2 0
Gain on sales of fixed assets (27) (8)
Other than temporary impairment on securities held-to-maturity 126 [1] 75 [1]
Losses and writedowns of other real estate owned 1,872 491
Gain on sales of investment securities 0 (603)
(Increase) decrease in accrued interest receivable (821) 1,039
Increase (decrease) in interest payable 4 7
(Increase) decrease in other assets (2,784) (2,110)
Increase (decrease) in other liablilities (396) (1,703)
Net cash provided by (used in) operating activities 19,464 15,160
Investing activities    
Purchase of investment securities available-for-sale (179,694) (194,522)
Proceeds from call of securities available-for-sale 0 4,000
Proceeds from sale of investment securities available-for-sale 0 23,581
Proceeds from redemptions and repayment of securities available-for-sale 49,048 55,647
Proceeds from sale of other real estate owned 2,504 769
Net (increase) decrease in loans (69,278) (70,387)
Proceeds from sale of fixed assets 139 45
Purchases of premises and equipment (1,769) (771)
Net cash provided by (used in) investing activities (199,050) (181,638)
Financing activities    
Net increase (decrease) in deposits 139,746 138,606
Net (decrease) increase in securities sold under agreements to repurchase (11,229) 5,875
Repayment of short-term borrowings and federal funds purchased 0 (136,000)
Proceeds from issuance of common stock 0 54,501
Proceeds from the exercise of options 39 0
Excess tax benefit from share-based payment arrangements (2) 0
Net cash provided by (used in) financing activities 128,554 62,982
Net increase (decrease) in cash and cash equivalents (51,032) (103,496)
Cash and cash equivalents, beginning of period 749,174 472,319
Cash and cash equivalents, end of period 698,142 368,823
Supplemental disclosure:    
Interest paid 6,029 5,959
Taxes paid 4,275 4,571
Transfers of loans to other real estate owned $ 1,890 $ 2,909
[1] Other than temporary impairment was due to credit loss and therefore did not include amounts due to market conditions.